Asthma medication receives new warning / (Record no. 70072)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01260nab a22002777a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | PILC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20221123181941.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 150723s9999 xx 000 0 und d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0002-936X |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | MANILA TYTANA COLLEGES LIBRARY |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Aschenbrenner, Diane S. |
| 245 00 - TITLE STATEMENT | |
| Title | Asthma medication receives new warning / |
| Statement of responsibility, etc. | Diane S. Aschenbrenner |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Date of publication, distribution, etc. | January 2015 |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE | |
| Title | American Journal of Nursing |
| Number of part/section of a work | 115 : 1, page 22-23 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The Food and Drug Administration has revised the warnings in the labeling of omalizumab (Xolair), a drug used in the treatment of allergic asthma. Omalizumab's labeling now warns that the drug may carry a slightly elevated risk of cardiovascular complications. Omalizumab is administered every two to four weeks as a subcutaneous injection to patients with moderate-to-severe persistent, allergic asthma and an elevated IgE level and whose allergic asthma symptoms aren't well controlled with corticosteroids. |
| 521 ## - TARGET AUDIENCE NOTE | |
| Target audience note | Nursing |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Labeling. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cardiovascular diseases. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Antiallergic agents. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Asthma. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drugs. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Descriptive labeling. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Articles |
| Source of classification or shelving scheme | Library of Congress Classification |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) | |
| Cataloger's initials, CIN (RLIN) | 71643 |
| First Date, FD (RLIN) | 130006 |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Full call number | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Library of Congress Classification | Not For Loan | Manila Tytana Colleges Library | Manila Tytana Colleges Library | REFERENCE SECTION | 08/04/2015 | Bound | 08/04/2015 | 08/04/2015 | Articles |